182 related articles for article (PubMed ID: 29167064)
1. The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancer.
Quinten C; Kenis C; Hamaker M; Coolbrandt A; Brouwers B; Dal Lago L; Neven P; Vuylsteke P; Debrock G; Van Den Bulck H; Smeets A; Schöffski P; Bottomley A; Wedding U; Wildiers H
J Geriatr Oncol; 2018 Mar; 9(2):152-162. PubMed ID: 29167064
[TBL] [Abstract][Full Text] [Related]
2. The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters.
Brouwers B; Hatse S; Dal Lago L; Neven P; Vuylsteke P; Dalmasso B; Debrock G; Van Den Bulck H; Smeets A; Bechter O; Bailur JK; Kenis C; Laenen A; Schöffski P; Pawelec G; Journe F; Ghanem GE; Wildiers H
Oncotarget; 2016 May; 7(21):29977-88. PubMed ID: 27102154
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
5. Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients.
Kool M; Fontein DB; Meershoek-Klein Kranenbarg E; Nortier JW; Rutgers EJ; Marang-van de Mheen PJ; van de Velde CJ
Breast; 2015 Jun; 24(3):224-9. PubMed ID: 25704982
[TBL] [Abstract][Full Text] [Related]
6. Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial.
Schwentner L; Harbeck N; Singer S; Eichler M; Rack B; Forstbauer H; Wischnik A; Scholz C; Huober J; Friedl TW; Weissenbacher T; Härtl K; Kiechle M; Janni W; Fink V
Breast; 2016 Jun; 27():69-77. PubMed ID: 27054751
[TBL] [Abstract][Full Text] [Related]
7. Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial.
Brain EG; Mertens C; Girre V; Rousseau F; Blot E; Abadie S; Uwer L; Bourbouloux E; Van Praagh-Doreau I; Mourey L; Kirscher S; Laguerre B; Fourme E; Luneau S; Genève J; Debled M
Crit Rev Oncol Hematol; 2011 Oct; 80(1):160-70. PubMed ID: 21035352
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23.
Land SR; Kopec JA; Yothers G; Anderson S; Day R; Tang G; Ganz PA; Fisher B; Wolmark N
Breast Cancer Res Treat; 2004 Jul; 86(2):153-64. PubMed ID: 15319567
[TBL] [Abstract][Full Text] [Related]
9. A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy.
Hurria A; Hurria A; Zuckerman E; Panageas KS; Fornier M; D'Andrea G; Dang C; Moasser M; Robson M; Seidman A; Currie V; VanPoznak C; Theodoulou M; Lachs MS; Hudis C
J Am Geriatr Soc; 2006 Jul; 54(7):1119-24. PubMed ID: 16866685
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal women.
Browall M; Ahlberg K; Karlsson P; Danielson E; Persson LO; Gaston-Johansson F
Eur J Oncol Nurs; 2008 Jul; 12(3):180-9. PubMed ID: 18343197
[TBL] [Abstract][Full Text] [Related]
11. [Autologous cytokine-induced killer cells therapy on the quality of life of patients with breast cancer after adjuvant chemotherapy: a prospective study].
Liang XF; Ma DC; Ding ZY; Liu ZZ; Guo F; Liu L; Yu HY; Han YL; Xie XD
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):764-8. PubMed ID: 24378099
[TBL] [Abstract][Full Text] [Related]
12. Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy.
Dalmasso B; Hatse S; Brouwers B; Laenen A; Berben L; Kenis C; Smeets A; Neven P; Schöffski P; Wildiers H
BMC Cancer; 2018 Oct; 18(1):1014. PubMed ID: 30348127
[TBL] [Abstract][Full Text] [Related]
13. Variability of patterns of fatigue and quality of life over time based on different breast cancer adjuvant chemotherapy regimens.
Berger AM; Lockhart K; Agrawal S
Oncol Nurs Forum; 2009 Sep; 36(5):563-70. PubMed ID: 19726396
[TBL] [Abstract][Full Text] [Related]
14. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
15. A planned, prospective comparison of short-term quality of life outcomes among older patients with breast cancer treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB #49907 and #369901.
Mandelblatt JS; Makgoeng SB; Luta G; Hurria A; Kimmick G; Isaacs C; Tallarico M; Barry WT; Pitcher B; Winer EP; Hudis C; Cohen HJ; Muss HB
J Geriatr Oncol; 2013 Oct; 4(4):353-61. PubMed ID: 24472479
[TBL] [Abstract][Full Text] [Related]
16. Prospective longitudinal evaluation of a symptom cluster in breast cancer.
Sanford SD; Beaumont JL; Butt Z; Sweet JJ; Cella D; Wagner LI
J Pain Symptom Manage; 2014 Apr; 47(4):721-30. PubMed ID: 23880589
[TBL] [Abstract][Full Text] [Related]
17. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life.
Byar KL; Berger AM; Bakken SL; Cetak MA
Oncol Nurs Forum; 2006 Jan; 33(1):E18-26. PubMed ID: 16470230
[TBL] [Abstract][Full Text] [Related]
18. Weight gain and quality of life in women treated with adjuvant chemotherapy for early-stage breast cancer.
McInnes JA; Knobf MT
Oncol Nurs Forum; 2001 May; 28(4):675-84. PubMed ID: 11383182
[TBL] [Abstract][Full Text] [Related]
19. Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study.
Chen BT; Sethi SK; Jin T; Patel SK; Ye N; Sun CL; Rockne RC; Haacke EM; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Somlo G; Li D; Yang R; Tan H; Katheria V; Morrison R; Hurria A
Breast Cancer Res; 2018 May; 20(1):38. PubMed ID: 29720224
[TBL] [Abstract][Full Text] [Related]
20. Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial.
Adams SC; Segal RJ; McKenzie DC; Vallerand JR; Morielli AR; Mackey JR; Gelmon K; Friedenreich CM; Reid RD; Courneya KS
Breast Cancer Res Treat; 2016 Aug; 158(3):497-507. PubMed ID: 27394134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
